Literature DB >> 27785206

Gastric Angiomyolipoma, a Very Rare Cause of Upper Gastrointestinal Bleeding: A Case Report and a Brief Review of Literature.

Raghava Reddy Levaka Veera1, Swapna Reddy Bemalgi1.   

Abstract

Angiomyolipoma (AML) is a tumor composed of variable proportions of adipose tissue, spindle and epithelioid smooth muscle-like cells and abnormal thick-walled blood vessels which are usually benign. AML is relatively common in kidney and liver. Gastric angiomyolipoma (GAML) is extremely rare and only 2 cases were reported in the literature. Diagnosis of AML is difficult owing to its rarity and varied immunohistochemical patterns. Here, we report a case of GAML in a 65-year-old male who presented with an episode of hematemesis and intermittent melena for one week. Endoscopy showed a partially obstructing mass arising from gastric antrum with central ulceration. Mass was removed by wedge resection after laparoscopic anterior gastrectomy. Excised specimen showed a benign 6 × 3 × 3 cm homogenous fatty mass with adipose tissue, smooth muscles and prominent vascularity. Immunohistochemistry stains were positive for desmin, smooth muscle actin (SMA), CD34 and negative for human melanoma black (HMB)-45 antigen and CD117. This case reports the largest and HMB-45 negative GAML so far, which can be a very rare cause of upper gastrointestinal bleeding.

Entities:  

Keywords:  Angiomyolipoma; EUS; GAML; Gastric; HMB-45

Year:  2012        PMID: 27785206      PMCID: PMC5051102          DOI: 10.4021/gr486e

Source DB:  PubMed          Journal:  Gastroenterology Res        ISSN: 1918-2805


  13 in total

Review 1.  Endoscopic ultrasound and endoscopic ultrasound-guided fine-needle biopsy for the diagnosis of malignant submucosal tumors.

Authors:  M Polkowski
Journal:  Endoscopy       Date:  2005-07       Impact factor: 10.093

Review 2.  Laparoscopic management of gastric angiomyolipoma: case report and review of literature.

Authors:  Sandeep Aggarwal; Pankaj Gupta; Sanjay Sharma
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2012-02       Impact factor: 1.719

3.  Clinicopathological analysis of 156 patients with angiomyolipoma originating from different organs.

Authors:  Lin Yang; Xiao-Li Feng; Steven Shen; Ling Shan; Hai-Feng Zhang; Xiu-Yun Liu; Ning Lv
Journal:  Oncol Lett       Date:  2012-01-03       Impact factor: 2.967

4.  Expression of KIT (CD117) in angiomyolipoma.

Authors:  Hala R Makhlouf; Helen E Remotti; Kamal G Ishak
Journal:  Am J Surg Pathol       Date:  2002-04       Impact factor: 6.394

5.  Laparoscopic management of gastrointestinal stromal tumors.

Authors:  S Q Nguyen; C M Divino; J-L Wang; S H Dikman
Journal:  Surg Endosc       Date:  2006-02-21       Impact factor: 4.584

6.  Characteristics and treatment strategy of hepatic angiomyolipoma: a series of 94 patients collected from four institutions.

Authors:  Zhi- Gang Chang; Jin Ming Zhang; Jiao Qian Ying; Yu Ping Ge
Journal:  J Gastrointestin Liver Dis       Date:  2011-03       Impact factor: 2.008

7.  Renal angiomyolipoma: long-term results after arterial embolization.

Authors:  Nishita Kothary; Michael C Soulen; Timothy W I Clark; A J Wein; Richard D Shlansky-Goldberg; Peter B Crino; S William Stavropoulos
Journal:  J Vasc Interv Radiol       Date:  2005-01       Impact factor: 3.464

8.  Renal angiomyolipomas and HMB-45 reactivity.

Authors:  R Ashfaq; A G Weinberg; J Albores-Saavedra
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

9.  Malignant hepatic angiomyolipoma: report of a case and review of literature.

Authors:  Thong T Nguyen; Blythe Gorman; David Shields; Zachary Goodman
Journal:  Am J Surg Pathol       Date:  2008-05       Impact factor: 6.394

Review 10.  Role of EUS and MDCT in the diagnosis of gastric submucosal tumors according to the revised pathologic concept of gastrointestinal stromal tumors.

Authors:  Jung-Ho Kang; Joon Seok Lim; Jie-Hyun Kim; Woo Jin Hyung; Yong Eun Chung; Jin-Young Choi; Mi-Suk Park; Myeong-Jin Kim; Ki Whang Kim
Journal:  Eur Radiol       Date:  2008-11-21       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.